share_log

SureNano Science Signs Licensing Agreement for the State of Oklahoma

SureNano Science Signs Licensing Agreement for the State of Oklahoma

SureNano Science為俄克拉荷馬州簽署許可協議
newsfile ·  2022/06/27 19:10

Vancouver, British Columbia--(Newsfile Corp. - June 27, 2022) - SURENANO SCIENCE LTD. (CSE: SURE) (the "Company" or "SureNano") is pleased to announce that it has signed a licensing agreement with 1150641 BC Ltd. ("1150641") for the exclusive rights to sell and distribute all current and future products developed by 1150641 (the "Agreement") in the state of Oklahoma (the "Territory"). Currently there is one product for sale: the SureNanoTM surfactant.

温哥華,不列顛哥倫比亞省-(Newsfile Corp.-2022年6月27日)-蘇雷納諾科技有限公司。(CSE:當然)(“公司“或”SureNano“)欣然宣佈已與1150641 BC Ltd.(”1150641“)獨家銷售和分銷1150641年開發的所有當前和未來的產品(”協議“)俄克拉何馬州(”領土目前只有一種產品在售:SureNanoTM表面活性劑。

The terms of the Agreement are that the Company agrees to pay $10,000. The Company will also pay quarterly a 20% royalty on all net sales. The term of the Agreement is for 10 years with an option to renew for an additional 10 years.

該協議的條款是該公司同意支付10,000美元。該公司還將按季度為所有淨銷售額支付20%的特許權使用費。該協議的期限為10年,並可選擇續簽10年。

The Company plans to find a licensed producer in Oklahoma to become a bulk supplier of nanoemulsions and further showcase the benefits of SureNanoTM surfactant.

該公司計劃在俄克拉何馬州找到一家獲得許可的生產商,成為納米乳液的批量供應商,並進一步展示SureNano的好處TM表面活性劑。

About SureNano Science Ltd.:

關於SureNano科學有限公司:

The business of SureNano Science Ltd. is the sale and distribution of the SureNano™ surfactant, which is a ready-to-mix food grade compound that provides the base for high performance nano-emulsions to create incredibly homogeneous and stable products while maximizing bioavailability, clarity, and taste. The Company has an exclusive license to distribute the SureNanoTM surfactant within Canada; Oklahoma, USA; and Colorado, USA.

SureNano Science Ltd.的業務是銷售和分銷SureNano™表面活性劑,這是一種隨時混合的食品級化合物,為高性能納米乳液提供基礎,在最大限度地提高生物利用度、透明度和口感的同時,創造出令人難以置信的均勻和穩定的產品。該公司擁有銷售SureNano的獨家許可證TM加拿大、美國俄克拉何馬州和美國科羅拉多州的表面活性劑。

ON BEHALF OF SURENANO SCIENCE LTD.

我代表SURENANO科學有限公司。

"Charles MaLette"
CEO, President, Director & Secretary
T: 604-428-5171
E: info@surenano.com

《查爾斯·馬萊特》
董事首席執行官、總裁兼祕書
T: 604-428-5171
電子郵箱:info@surenano.com

Forward-Looking Information:
This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of SureNano. Forward-looking information is based on certain key expectations and assumptions made by the management of SureNano. In some cases, you can identify forward-looking statements by the use of words such as "will," "may," "would," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "could" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Forward-looking statements in this press release include that (a) the Company will also pay quarterly a 20% royalty on all net sales, and (b) the Company will find a licensed producer in Oklahoma to become a bulk supplier. Although SureNano believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because SureNano can give no assurance that they will prove to be correct.

前瞻性信息:
本新聞稿可能包括加拿大證券法規定的有關SureNano業務的前瞻性信息。前瞻性信息是基於SureNano管理層做出的某些關鍵預期和假設。在某些情況下,您可以通過使用“將”、“可能”、“將”、“預期”、“打算”、“計劃”、“尋求”、“預期”、“相信”、“估計”、“預測”、“潛在”、“繼續”、“可能”、“可能”以及這些術語和類似表述的變體,或這些術語或類似表述的否定詞來識別前瞻性陳述。本新聞稿中的前瞻性陳述包括:(A)公司還將每季度為所有淨銷售額支付20%的特許權使用費,(B)公司將在俄克拉何馬州尋找一家獲得許可的生產商成為大宗供應商。儘管SureNano認為這些前瞻性信息所基於的預期和假設是合理的,但不應過度依賴前瞻性信息,因為SureNano不能保證它們將被證明是正確的。

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.

加拿大證券交易所(CSE)沒有對本新聞稿內容的充分性或準確性進行審查,也不承擔任何責任。

To view the source version of this press release, please visit

要查看本新聞稿的源版本,請訪問

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論